Atlas Trials

Effects of Ondansetron in Obsessive-compulsive and Tic Disorders

Clinical trial NCT03239210 · COMPLETED

Trial details

NCT number
NCT03239210
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Obsessive-Compulsive DisorderTic DisordersTourette Syndrome
Start date
2017-06-16
Primary completion
2022-05-16
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.